Insights

Expansion into oncology market Recent partnerships and product launches, such as BORUZU, a novel oncology drug, present a significant sales opportunity for Amneal Pharmaceuticals to establish a stronger foothold in the oncology market.

Diversification with mesalamine tablets The launch of mesalamine 800 mg delayed-release tablets for ulcerative colitis treatment showcases Amneal's commitment to diversifying its product portfolio, indicating potential sales growth opportunities within the gastroenterology market segment.

Innovative biosimilar agreements with Mabxience Amneal's partnership with Mabxience for the US market on a bevacizumab biosimilar candidate highlights the company's innovative approach to biosimilar agreements, opening doors for sales expansion in the biopharmaceutical market.

Successful product launches - CREXONT The successful launch of CREXONT and the achievement of reduced net leverage demonstrate Amneal Pharmaceuticals' ability to bring new products to market effectively, indicating a positive sales momentum that can be leveraged for further growth.

Participation in global healthcare conference Amneal Pharmaceuticals' participation in the Barclays 27th Annual Global Healthcare Conference signifies its proactive engagement with key stakeholders in the healthcare industry, presenting opportunities for networking, collaborations, and potential sales partnerships.

Similar companies to Amneal Pharmaceuticals

Amneal Pharmaceuticals Tech Stack

Amneal Pharmaceuticals uses 8 technology products and services including Level 5, Shopify, Adobe Sign, and more. Explore Amneal Pharmaceuticals's tech stack below.

  • Level 5
    Advertising
  • Shopify
    E-commerce
  • Adobe Sign
    Electronic Signatures
  • Veeva Vault
    Enterprise Content Management
  • Calibre
    Performance
  • New Relic
    Real User Monitoring
  • VMware ESXi
    Virtualisation Software
  • Webex
    Web Conferencing

Media & News

Amneal Pharmaceuticals's Email Address Formats

Amneal Pharmaceuticals uses at least 1 format(s):
Amneal Pharmaceuticals Email FormatsExamplePercentage
First.Last@amneal.comJohn.Doe@amneal.com
53%
FLast@amneal.comJDoe@amneal.com
25%
FirstL@amneal.comJohnD@amneal.com
15%
First@amneal.comJohn@amneal.com
7%

Frequently Asked Questions

Where is Amneal Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Amneal Pharmaceuticals's main headquarters is located at 400 Crossing Boulevard Bridgewater, New Jersey 08807 US. The company has employees across 6 continents, including North AmericaAsiaEurope.

What is Amneal Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Amneal Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Amneal Pharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
Amneal Pharmaceuticals is a publicly traded company; the company's stock symbol is AMRX.

What is Amneal Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Amneal Pharmaceuticals's official website is amneal.com and has social profiles on LinkedIn.

How much revenue does Amneal Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of April 2025, Amneal Pharmaceuticals's annual revenue reached $1B.

What is Amneal Pharmaceuticals's NAICS code?

Minus sign iconPlus sign icon
Amneal Pharmaceuticals's NAICS code is 325412 - Pharmaceutical Preparation Manufacturing.

How many employees does Amneal Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of April 2025, Amneal Pharmaceuticals has approximately 6K employees across 6 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: P. R.Chief Executive Officer: S. M.Chief Quality Officer: S. K. J.. Explore Amneal Pharmaceuticals's employee directory with LeadIQ.

What industry does Amneal Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Amneal Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Amneal Pharmaceuticals use?

Minus sign iconPlus sign icon
Amneal Pharmaceuticals's tech stack includes Level 5ShopifyAdobe SignVeeva VaultCalibreNew RelicVMware ESXiWebex.

What is Amneal Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Amneal Pharmaceuticals's email format typically follows the pattern of . Find more Amneal Pharmaceuticals email formats with LeadIQ.

How much funding has Amneal Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of April 2025, Amneal Pharmaceuticals has raised $2.4B in funding. The last funding round occurred on Nov 16, 2023 for $2.4B.

When was Amneal Pharmaceuticals founded?

Minus sign iconPlus sign icon
Amneal Pharmaceuticals was founded in 2002.
Amneal Pharmaceuticals

Amneal Pharmaceuticals

Pharmaceutical ManufacturingNew Jersey, United States5001-10000 Employees

Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Our family delivers for yours through a robust U.S. generics business, a growing branded business and deepening portfolios in injectables, biosimilars and select international markets. We’ve bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. And we invest substantially in our people through leadership development and employee well-being programs – all so we can deliver even more value.  We are Amneal and We make healthy possible.

Content is for informational purposes only and 3rd party content does not reflect Amneal’s opinions.

Amneal has the right to remove comments that violate another’s copyright or intellectual property, mention an Amneal product, use profanity or are defamatory, promote and solicit for third-party sites, initiatives, or products, or are factually inaccurate or misleading or spam.

Amneal recommends that you consult with your healthcare provider regarding personal health matters. To report a product complaint or adverse event related to an Amneal product, contact Drug Safety at 877-835-5472, option 3 or drugsafety@amneal.com. If you are currently experiencing a life-threatening event, please immediately contact 911.

Section iconCompany Overview

Headquarters
400 Crossing Boulevard Bridgewater, New Jersey 08807 US
Phone number
Website
amneal.com
Stock Symbol
AMRX
NAICS Code
325412 - Pharmaceutical Preparation Manufacturing
Founded
2002
Employees
5001-10000

Section iconFunding & Financials

  • $2.4B

    Amneal Pharmaceuticals has raised a total of $2.4B of funding over 3 rounds. Their latest funding round was raised on Nov 16, 2023 in the amount of $2.4B.

  • $1B

    Amneal Pharmaceuticals's revenue is in the range of $1B

Section iconFunding & Financials

  • $2.4B

    Amneal Pharmaceuticals has raised a total of $2.4B of funding over 3 rounds. Their latest funding round was raised on Nov 16, 2023 in the amount of $2.4B.

  • $1B

    Amneal Pharmaceuticals's revenue is in the range of $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.